CD40LG and rheumatoid arthritis: Anti-CCP antibodies, which were first described in 1998, were found to be highly specific in the diagnosis of RA (95%) and only slightly less sensitive than IgM RF (60% to 70%) [6,7], whereas the second generation of anti-CCP antibodies have a sensitivity of 80% and a specificity of 98%.